EGFR protein overexpression correlates with chromosome 7 polysomy and poor prognostic parameters in clear cell renal cell carcinoma

被引:34
作者
Dordevic, Gordana [1 ]
Ilijas, Koviljka Matusan [1 ]
Hadzisejdic, Ita [1 ]
Maricic, Anton [2 ]
Grahovac, Blazenka [1 ]
Jonjic, Nives [1 ]
机构
[1] Univ Rijeka, Sch Med, Dept Pathol, Rijeka 51000, Croatia
[2] Rijeka Univ Hosp Ctr, Dept Urol, Rijeka 51000, Croatia
关键词
Carcinoma; Renal cell; Chromosome; 7; EGFR; In Situ Hybridization; Fluorescence; Prognosis; GROWTH-FACTOR RECEPTOR; COPY NUMBER CHANGES; EXPRESSION; ACTIVATION; MUTATION; CANCER;
D O I
10.1186/1423-0127-19-40
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: The role of epidermal growth factor (EGF) and its receptor (EGFR) in the pathogenesis and progression of various malignant tumors has long been known, but there is still disagreement concerning prognostic significance of EGFR expression in clear cell renal cell carcinoma (CCRCC). The present study was designed to analyze more objectively the protein EGFR expression in CCRCC and to compare its value with EGFR gene copy number changes and clinicopathologic characteristics including patient survival. Methods: The protein EGFR expression was analyzed immunohistochemically on 94 CCRCC, and gene copy number alterations of EGFR by FISH analysis on 41 CCRCC selected according to distinct membrane EGFR staining. Results: Membrane EGFR expression in tumor cells was heterogeneous with respect to the proportion of positive cells and staining intensity. FISH analysis did not reveal EGFR gene amplification, while polysomy of chromosome 7 found in 41% was associated with higher EGFR membrane expression. Moreover, EGFR overexpression was associated with a higher nuclear grade, larger tumor size and shorter patient's survival, while there was no connection with pathological stage. Conclusion: In conclusion, the protein expression of EGFR had an impact on prognosis in patients with CCRCC, while an increased copy number of chromosome 7 could be the possible reason for EGFR protein overexpression in the absence of gene amplification.
引用
收藏
页数:8
相关论文
共 34 条
[1]  
[Anonymous], 2009, TNM Classification of Malignant Tumors
[2]  
Baselga J, 2001, EUR J CANCER, V37, pS16
[3]   EGFR FISH versus mutation: Different tests, different end-points [J].
Cappuzzo, Federico .
LUNG CANCER, 2008, 60 (02) :160-165
[4]   The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: A call for standardized methods for immunohistochemical evaluation [J].
Cohen, David ;
Lane, Brian ;
Jin, Tao ;
Magi-Galluzzi, Cristina ;
Finke, James ;
Rini, Brian I. ;
Bukowski, Ronald M. ;
Zhou, Ming .
CLINICAL GENITOURINARY CANCER, 2007, 5 (04) :264-270
[5]   Epidermal growth factor receptor and epidermal growth factor receptor therapies in renal cell carcinoma: Do we need a better mouse trap? [J].
Dancey, JE .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) :2975-2977
[6]  
Eble J N., 2004, World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs, P9
[7]   PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663
[8]   Tissue microarrays: emerging standard for biomarker validation [J].
Hassan, Saima ;
Ferrario, Cristiano ;
Mamo, Aline ;
Basik, Mark .
CURRENT OPINION IN BIOTECHNOLOGY, 2008, 19 (01) :19-25
[9]  
Hofmockel G, 1997, EUR UROL, V31, P478
[10]   Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma [J].
Kallio, JP ;
Hirvikoski, P ;
Helin, H ;
Kellokumpu-Lehtinen, P ;
Luukkaala, T ;
Tammela, TLJ ;
Martikainen, PM .
BRITISH JOURNAL OF CANCER, 2003, 89 (07) :1266-1269